載入...
Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial
AIMS: The SHIFT trial showed that ivabradine reduced heart rate (HR) and the risk of cardiovascular outcomes. Concerns remain over the efficacy and safety of ivabradine on heart failure (HF) due to Chagas disease (ChD). We therefore conducted a post hoc analysis of the SHIFT trial to investigate the...
Na minha lista:
| 發表在: | ESC Heart Fail |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933959/ https://ncbi.nlm.nih.gov/pubmed/29266804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12240 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|